Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

OncoSil Medical Ltd

Investor presentation - OncoSil Medical Ltd

ASX:OSL

OncoSil Medical Ltd

Health

OncoSil Medical Limited (OSL, NeuroDiscovery Ltd) is an Australia-based company which is engaged in the development of an innovative brachytherapy (internal radiotherapy) product, OncoSil, for the treatment of pancreatic cancer, after its acquisition of Enigma Therapeutics Ltd, a UK based cancer company. Former Names NeuroDiscovery Ltd (NDL), 31/05/2013.

Read more

Market Cap

$106.06m

Price at Close

$0.13

4w avg. Volume

973.76k

4w avg. Turnover

$124.19k

Announcements
announcementt+2 movementdate
  • Initial Director's Interest Notice

    Shareholder Details

  • -

    21 Jan 2021

-

21 Jan 2021
  • Appointment of Chief Executive Officer

    Company Administration · Market sensitive

  • -

    21 Jan 2021

-

21 Jan 2021
  • OncoSil FY21 half yearly review

    Progress Report · Market sensitive

  • 0.00%

    18 Jan 2021

0.00%

18 Jan 2021
  • Final Director's Interest Notice

    Shareholder Details

  • -3.85%

    18 Dec 2020

-3.85%

18 Dec 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • -3.85%

    18 Dec 2020

-3.85%

18 Dec 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • -3.85%

    18 Dec 2020

-3.85%

18 Dec 2020
  • Cancellation of shares under the Employee Share Plan

    Issued Capital

  • -3.85%

    18 Dec 2020

-3.85%

18 Dec 2020
  • Termination of Mr Daniel Kenny as Chief Executive Officer

    Company Administration · Market sensitive

  • -12.12%

    01 Dec 2020

-12.12%

01 Dec 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • +6.25%

    05 Nov 2020

+6.25%

05 Nov 2020
  • Appendix 2A

    Issued Capital

  • +6.25%

    05 Nov 2020

+6.25%

05 Nov 2020
Market Data

Current Price

$0.13

52WK HIGH

$0.215

52WK LOW

$0.082

1YR RETURN

-21.21%

1YR RETURN VS. SECTOR

-58.24%

90 DAY RETURN

-3.70%

ASX RANK

868

/2,048

SECTOR RANK

74

/168

SHARES OUTSTANDING

815.88m
ASX:OSL

OncoSil Medical Ltd

Health

OncoSil Medical Limited (OSL, NeuroDiscovery Ltd) is an Australia-based company which is engaged in the development of an innovative brachytherapy (internal radiotherapy) product, OncoSil, for the treatment of pancreatic cancer, after its acquisition of Enigma Therapeutics Ltd, a UK based cancer company. Former Names NeuroDiscovery Ltd (NDL), 31/05/2013.

Read more

Market Cap

$106.06m

Price at Close

$0.13

4w avg. Volume

973.76k

4w avg. Turnover

$124.19k

ASX:OSL is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.